Trevi Therapeutics, Inc. TRVI Proceeds From Offering Net Of Commissions
Proceeds From Offering Net Of Commissions at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept trvi:ProceedsFromOfferingNetOfCommissions.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s proceeds from offering net of commissions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s proceeds from offering net of commissions?
- Trevi Therapeutics, Inc. (TRVI) reported proceeds from offering net of commissions of $27.04M in Q4 2025.
- How has Trevi Therapeutics, Inc.'s proceeds from offering net of commissions changed year-over-year?
- Trevi Therapeutics, Inc.'s proceeds from offering net of commissions increased by 130.1% year-over-year, from $11.75M to $27.04M.
- What does proceeds from offering net of commissions mean?
- This represents the net cash inflows received from the issuance of equity or debt securities after deducting underwriting discounts and commissions paid to financial intermediaries. It serves as a primary indicator of the company's ability to raise external capital to fund clinical trials and operational burn. Tracking this provides insight into the company's success in accessing public markets to support its long-term development pipeline.